# PeptideScanner evidence objects: Thymosin beta-4

Every published version of the records placed with Thymosin beta-4, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json. Selected public evidence only; not medical advice.

- Objects: 32
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00382174-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT00382174

> PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct00382174-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2010-02-01
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00382174-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct00382174-thymosin-beta-4-v1
- Content SHA-256: `706918ca16c0a025fe5adecb15bef04260a6653fbcdb81f265828899a77a9bfc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00382174 ([`ctg-observation-nct00382174-2010-02-01-c721e9358d9c`](#source-ctg-observation-nct00382174-2010-02-01-c721e9358d9c))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct00382174-2010-02-01-c721e9358d9c`](#source-ctg-observation-nct00382174-2010-02-01-c721e9358d9c))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct00382174-2010-02-01-c721e9358d9c`](#source-ctg-observation-nct00382174-2010-02-01-c721e9358d9c))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00382174-2010-02-01-c721e9358d9c`](#source-ctg-observation-nct00382174-2010-02-01-c721e9358d9c))

### Sources

<a id="source-ctg-observation-nct00382174-2010-02-01-c721e9358d9c"></a>
- **ClinicalTrials.gov record NCT00382174 · retained source version 2010-02-01:c721e9358d9c03c06fb3e18d214503e2148f80af5aa10620fe1221b2d9837097** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00382174) (`ctg-observation-nct00382174-2010-02-01-c721e9358d9c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00382174." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct00382174-thymosin-beta-4-v1 SHA-256: 706918ca16c0a025fe5adecb15bef04260a6653fbcdb81f265828899a77a9bfc.

---

<a id="clinicaltrials-gov-nct00832091-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT00832091

> PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct00832091-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2010-03-30
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00832091-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct00832091-thymosin-beta-4-v1
- Content SHA-256: `daca69e9b03102be53912e4176cdb14dee7c9ba87b4cb8dd16219cb93f5bc2c7`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00832091 ([`ctg-observation-nct00832091-2010-03-30-45216971d18f`](#source-ctg-observation-nct00832091-2010-03-30-45216971d18f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct00832091-2010-03-30-45216971d18f`](#source-ctg-observation-nct00832091-2010-03-30-45216971d18f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct00832091-2010-03-30-45216971d18f`](#source-ctg-observation-nct00832091-2010-03-30-45216971d18f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00832091-2010-03-30-45216971d18f`](#source-ctg-observation-nct00832091-2010-03-30-45216971d18f))

### Sources

<a id="source-ctg-observation-nct00832091-2010-03-30-45216971d18f"></a>
- **ClinicalTrials.gov record NCT00832091 · retained source version 2010-03-30:45216971d18f0901f3ca739bfd16411400de886073bdcc94882275ad2850c1d2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00832091) (`ctg-observation-nct00832091-2010-03-30-45216971d18f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00832091." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct00832091-thymosin-beta-4-v1 SHA-256: daca69e9b03102be53912e4176cdb14dee7c9ba87b4cb8dd16219cb93f5bc2c7.

---

<a id="clinicaltrials-gov-nct01387347-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT01387347

> PeptideScanner retained ClinicalTrials.gov record NCT01387347 at 2026-11-16T01:44:56.605Z. Its registry update date was 2015-07-10, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct01387347-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2015-07-10
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01387347-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct01387347-thymosin-beta-4-v1
- Content SHA-256: `1d0be834726075a04d2640381676b837dbd67a77dcf1bf99313c4c69c825b673`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01387347 ([`ctg-observation-nct01387347-2015-07-10-27fd9905193c`](#source-ctg-observation-nct01387347-2015-07-10-27fd9905193c))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01387347 at 2026-11-16T01:44:56.605Z. Its registry update date was 2015-07-10, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct01387347-2015-07-10-27fd9905193c`](#source-ctg-observation-nct01387347-2015-07-10-27fd9905193c))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01387347 at 2026-11-16T01:44:56.605Z. Its registry update date was 2015-07-10, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct01387347-2015-07-10-27fd9905193c`](#source-ctg-observation-nct01387347-2015-07-10-27fd9905193c))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01387347-2015-07-10-27fd9905193c`](#source-ctg-observation-nct01387347-2015-07-10-27fd9905193c))

### Sources

<a id="source-ctg-observation-nct01387347-2015-07-10-27fd9905193c"></a>
- **ClinicalTrials.gov record NCT01387347 · retained source version 2015-07-10:27fd9905193cbf418e5ad5d9c0186d53c0553ce768cedef3734f13d8e26dd01c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01387347) (`ctg-observation-nct01387347-2015-07-10-27fd9905193c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01387347." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct01387347-thymosin-beta-4-v1 SHA-256: 1d0be834726075a04d2640381676b837dbd67a77dcf1bf99313c4c69c825b673.

---

<a id="clinicaltrials-gov-nct02597803-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT02597803

> PeptideScanner retained ClinicalTrials.gov record NCT02597803 at 2026-11-16T01:44:56.605Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct02597803-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-10-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02597803-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct02597803-thymosin-beta-4-v1
- Content SHA-256: `b593b800b3e4435736e85ffc5e0944b112d778724f26545be070a67bc82fb400`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02597803 ([`ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5`](#source-ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02597803 at 2026-11-16T01:44:56.605Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5`](#source-ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02597803 at 2026-11-16T01:44:56.605Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5`](#source-ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5`](#source-ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5))

### Sources

<a id="source-ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5"></a>
- **ClinicalTrials.gov record NCT02597803 · retained source version 2019-10-17:34bc46c7d6c51eaaa022a9974a79a78f8518df62530438e2e6f1a8f33a3e463e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02597803) (`ctg-observation-nct02597803-2019-10-17-34bc46c7d6c5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02597803." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct02597803-thymosin-beta-4-v1 SHA-256: b593b800b3e4435736e85ffc5e0944b112d778724f26545be070a67bc82fb400.

---

<a id="clinicaltrials-gov-nct02974907-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT02974907

> PeptideScanner retained ClinicalTrials.gov record NCT02974907 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-10-21, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct02974907-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-10-21
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02974907-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct02974907-thymosin-beta-4-v1
- Content SHA-256: `c6c99b7f17786063268017cd9fbf29c2aa170fcde7ba509761abbdb9c47e6478`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02974907 ([`ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad`](#source-ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02974907 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-10-21, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad`](#source-ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02974907 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-10-21, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad`](#source-ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad`](#source-ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad))

### Sources

<a id="source-ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad"></a>
- **ClinicalTrials.gov record NCT02974907 · retained source version 2026-10-21:59d27b0ae4adbcd8f812122dcc9a82866c0f1fdbfd494696a0d39d98746205ec** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02974907) (`ctg-observation-nct02974907-2026-10-21-59d27b0ae4ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02974907." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct02974907-thymosin-beta-4-v1 SHA-256: c6c99b7f17786063268017cd9fbf29c2aa170fcde7ba509761abbdb9c47e6478.

---

<a id="clinicaltrials-gov-nct03937882-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT03937882

> PeptideScanner retained ClinicalTrials.gov record NCT03937882 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct03937882-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03937882-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct03937882-thymosin-beta-4-v1
- Content SHA-256: `f29d0cea20ae4de0784d05962d236651ee895190d829abde35dd9b5679b20e6d`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03937882 ([`ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf`](#source-ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03937882 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf`](#source-ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03937882 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf`](#source-ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf`](#source-ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf))

### Sources

<a id="source-ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf"></a>
- **ClinicalTrials.gov record NCT03937882 · retained source version 2026-08-28:3dfc2e0bb1bf0e61f3aac55a4206c16633cb979290ddb57d04f4925082b71139** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03937882) (`ctg-observation-nct03937882-2026-08-28-3dfc2e0bb1bf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03937882." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct03937882-thymosin-beta-4-v1 SHA-256: f29d0cea20ae4de0784d05962d236651ee895190d829abde35dd9b5679b20e6d.

---

<a id="clinicaltrials-gov-nct05555589-thymosin-beta-4-v1"></a>

## ClinicalTrials.gov record NCT05555589

> PeptideScanner retained ClinicalTrials.gov record NCT05555589 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

- Evidence object: `story:clinicaltrials-gov-nct05555589-thymosin-beta-4:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-05
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05555589-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct05555589-thymosin-beta-4-v1
- Content SHA-256: `a642a6a2751038099a2372744ff9033e9057a1228548e5a28dacc6c780749044`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05555589 ([`ctg-observation-nct05555589-2026-11-05-e825071554db`](#source-ctg-observation-nct05555589-2026-11-05-e825071554db))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05555589 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct05555589-2026-11-05-e825071554db`](#source-ctg-observation-nct05555589-2026-11-05-e825071554db))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05555589 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was thymosin-beta-4. ([`ctg-observation-nct05555589-2026-11-05-e825071554db`](#source-ctg-observation-nct05555589-2026-11-05-e825071554db))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05555589-2026-11-05-e825071554db`](#source-ctg-observation-nct05555589-2026-11-05-e825071554db))

### Sources

<a id="source-ctg-observation-nct05555589-2026-11-05-e825071554db"></a>
- **ClinicalTrials.gov record NCT05555589 · retained source version 2026-11-05:e825071554db7d2d13c4137e49cc1e7ca4c82e221422addc412bad3045733106** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05555589) (`ctg-observation-nct05555589-2026-11-05-e825071554db`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05555589." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#clinicaltrials-gov-nct05555589-thymosin-beta-4-v1 SHA-256: a642a6a2751038099a2372744ff9033e9057a1228548e5a28dacc6c780749044.

---

<a id="pubmed-pmid-12852258-thymosin-beta-4-v1"></a>

## Thymosin beta 4 interactions.

> PubMed lists PMID 12852258 in Vitamins and hormones as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-12852258-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12852258-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-12852258-thymosin-beta-4-v1
- Content SHA-256: `904f5a8a67cac3241e663d71827c3363cb777f03994027dcfe29d488a1dc1b75`

### Claims and source pins

#### Headline

Thymosin beta 4 interactions. ([`pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f`](#source-pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f))

#### Summary

PubMed lists PMID 12852258 in Vitamins and hormones as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f`](#source-pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f))

#### Paragraph 1

PubMed lists PMID 12852258 in Vitamins and hormones as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f`](#source-pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f`](#source-pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f))

### Sources

<a id="source-pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f"></a>
- **Thymosin beta 4 interactions. · retained source version 1:2026-01-28:current:3bd79600d91f64084291ea199356bb965916c61a1d9b2c0734aa5c2425d59b83** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12852258/) (`pubmed-observation-pmid-12852258-2026-01-28-3bd79600d91f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4 interactions." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-12852258-thymosin-beta-4-v1 SHA-256: 904f5a8a67cac3241e663d71827c3363cb777f03994027dcfe29d488a1dc1b75.

---

<a id="pubmed-pmid-17495249-thymosin-beta-4-v1"></a>

## Thymosin beta-4 and the eye: I can see clearly now the pain is gone.

> PubMed lists PMID 17495249 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2007-05-10 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17495249-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17495249-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-17495249-thymosin-beta-4-v1
- Content SHA-256: `35e01cc00a1fabf02856d57a877229ae0f85c11e5f0c61fc7b87f195d554b5cd`

### Claims and source pins

#### Headline

Thymosin beta-4 and the eye: I can see clearly now the pain is gone. ([`pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1`](#source-pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1))

#### Summary

PubMed lists PMID 17495249 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2007-05-10 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1`](#source-pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1))

#### Paragraph 1

PubMed lists PMID 17495249 in Annals of the New York Academy of Sciences as Journal Article, Review, with publication-date metadata of 2007-05-10 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1`](#source-pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1`](#source-pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1))

### Sources

<a id="source-pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1"></a>
- **Thymosin beta-4 and the eye: I can see clearly now the pain is gone. · retained source version 1:2026-01-28:current:1151d9a090c17862aa908394e27502563aae7c21264ae38cab108079745fb014** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17495249/) (`pubmed-observation-pmid-17495249-2026-01-28-1151d9a090c1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta-4 and the eye: I can see clearly now the pain is gone." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-17495249-thymosin-beta-4-v1 SHA-256: 35e01cc00a1fabf02856d57a877229ae0f85c11e5f0c61fc7b87f195d554b5cd.

---

<a id="pubmed-pmid-22158707-thymosin-beta-4-v1"></a>

## Thymosin beta 4 is dispensable for murine cardiac development and function.

> PubMed lists PMID 22158707 in Circulation research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-12-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-22158707-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-22158707-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-22158707-thymosin-beta-4-v1
- Content SHA-256: `c85d170ad1bf447f276f386e052242f9572214a15442ca2839d6733fd96a20ed`

### Claims and source pins

#### Headline

Thymosin beta 4 is dispensable for murine cardiac development and function. ([`pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1`](#source-pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1))

#### Summary

PubMed lists PMID 22158707 in Circulation research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-12-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1`](#source-pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1))

#### Paragraph 1

PubMed lists PMID 22158707 in Circulation research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-12-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1`](#source-pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1`](#source-pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1))

### Sources

<a id="source-pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1"></a>
- **Thymosin beta 4 is dispensable for murine cardiac development and function. · retained source version 1:2026-01-28:current:16c900df59d1748d3027c5b3eb379585dcc0c780e3b200b06e32fb0884864ebb** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/22158707/) (`pubmed-observation-pmid-22158707-2026-01-28-16c900df59d1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4 is dispensable for murine cardiac development and function." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-22158707-thymosin-beta-4-v1 SHA-256: c85d170ad1bf447f276f386e052242f9572214a15442ca2839d6733fd96a20ed.

---

<a id="pubmed-pmid-23052839-thymosin-beta-4-v1"></a>

## Multiple functional involvement of thymosin beta-4 in tooth germ development.

> PubMed lists PMID 23052839 in Histochemistry and cell biology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23052839-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23052839-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23052839-thymosin-beta-4-v1
- Content SHA-256: `ac71db4a5f26d55643f164981db5c594ddbb889b036a69c95f067a4c9a01be37`

### Claims and source pins

#### Headline

Multiple functional involvement of thymosin beta-4 in tooth germ development. ([`pubmed-observation-pmid-23052839-2026-01-28-7303604e0898`](#source-pubmed-observation-pmid-23052839-2026-01-28-7303604e0898))

#### Summary

PubMed lists PMID 23052839 in Histochemistry and cell biology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23052839-2026-01-28-7303604e0898`](#source-pubmed-observation-pmid-23052839-2026-01-28-7303604e0898))

#### Paragraph 1

PubMed lists PMID 23052839 in Histochemistry and cell biology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23052839-2026-01-28-7303604e0898`](#source-pubmed-observation-pmid-23052839-2026-01-28-7303604e0898))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23052839-2026-01-28-7303604e0898`](#source-pubmed-observation-pmid-23052839-2026-01-28-7303604e0898))

### Sources

<a id="source-pubmed-observation-pmid-23052839-2026-01-28-7303604e0898"></a>
- **Multiple functional involvement of thymosin beta-4 in tooth germ development. · retained source version 1:2026-01-28:current:7303604e08983493d029b586ca7c51c96cc2abd509d324aa44d2209dccccb41a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23052839/) (`pubmed-observation-pmid-23052839-2026-01-28-7303604e0898`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Multiple functional involvement of thymosin beta-4 in tooth germ development." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23052839-thymosin-beta-4-v1 SHA-256: ac71db4a5f26d55643f164981db5c594ddbb889b036a69c95f067a4c9a01be37.

---

<a id="pubmed-pmid-23711379-thymosin-beta-4-v1"></a>

## Production and characterization of highly purified recombinant thymosin beta 4 in Escherichia coli.

> PubMed lists PMID 23711379 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-24 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23711379-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23711379-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23711379-thymosin-beta-4-v1
- Content SHA-256: `dce9986089269de7a9d650c7827ff33f45980ae877706d336fef8036b346e075`

### Claims and source pins

#### Headline

Production and characterization of highly purified recombinant thymosin beta 4 in Escherichia coli. ([`pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af`](#source-pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af))

#### Summary

PubMed lists PMID 23711379 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-24 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af`](#source-pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af))

#### Paragraph 1

PubMed lists PMID 23711379 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-24 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af`](#source-pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af`](#source-pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af))

### Sources

<a id="source-pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af"></a>
- **Production and characterization of highly purified recombinant thymosin beta 4 in Escherichia coli. · retained source version 1:2026-01-28:current:6e31ba02d1af7f55222e0c54f80869cdf648f3802b3dbb0599195e46967ae100** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23711379/) (`pubmed-observation-pmid-23711379-2026-01-28-6e31ba02d1af`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Production and characterization of highly purified recombinant thymosin beta 4 in Escherichia coli." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23711379-thymosin-beta-4-v1 SHA-256: dce9986089269de7a9d650c7827ff33f45980ae877706d336fef8036b346e075.

---

<a id="pubmed-pmid-23747515-thymosin-beta-4-v1"></a>

## Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer.

> PubMed lists PMID 23747515 in Clinical biochemistry as Journal Article, with publication-date metadata of 2013-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23747515-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23747515-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23747515-thymosin-beta-4-v1
- Content SHA-256: `01f17a9565a4cc1fd9ec64de9e001e62027455a6e7219e1077618c28720d47fb`

### Claims and source pins

#### Headline

Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer. ([`pubmed-observation-pmid-23747515-2026-01-28-39e94902048a`](#source-pubmed-observation-pmid-23747515-2026-01-28-39e94902048a))

#### Summary

PubMed lists PMID 23747515 in Clinical biochemistry as Journal Article, with publication-date metadata of 2013-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23747515-2026-01-28-39e94902048a`](#source-pubmed-observation-pmid-23747515-2026-01-28-39e94902048a))

#### Paragraph 1

PubMed lists PMID 23747515 in Clinical biochemistry as Journal Article, with publication-date metadata of 2013-06-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23747515-2026-01-28-39e94902048a`](#source-pubmed-observation-pmid-23747515-2026-01-28-39e94902048a))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23747515-2026-01-28-39e94902048a`](#source-pubmed-observation-pmid-23747515-2026-01-28-39e94902048a))

### Sources

<a id="source-pubmed-observation-pmid-23747515-2026-01-28-39e94902048a"></a>
- **Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer. · retained source version 1:2026-01-28:current:39e94902048a9b74759b9c06f0ea977d245d94315139b0656031ee65f399bc69** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23747515/) (`pubmed-observation-pmid-23747515-2026-01-28-39e94902048a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23747515-thymosin-beta-4-v1 SHA-256: 01f17a9565a4cc1fd9ec64de9e001e62027455a6e7219e1077618c28720d47fb.

---

<a id="pubmed-pmid-23807296-thymosin-beta-4-v1"></a>

## Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract.

> PubMed lists PMID 23807296 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-07 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23807296-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23807296-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23807296-thymosin-beta-4-v1
- Content SHA-256: `0b3c172fc5bfc9516d26ac05bcf9a8626feb61c6bd2c5300deab7c8aaf1fcdeb`

### Claims and source pins

#### Headline

Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract. ([`pubmed-observation-pmid-23807296-2026-01-28-8c984451104f`](#source-pubmed-observation-pmid-23807296-2026-01-28-8c984451104f))

#### Summary

PubMed lists PMID 23807296 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-07 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23807296-2026-01-28-8c984451104f`](#source-pubmed-observation-pmid-23807296-2026-01-28-8c984451104f))

#### Paragraph 1

PubMed lists PMID 23807296 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-07 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23807296-2026-01-28-8c984451104f`](#source-pubmed-observation-pmid-23807296-2026-01-28-8c984451104f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23807296-2026-01-28-8c984451104f`](#source-pubmed-observation-pmid-23807296-2026-01-28-8c984451104f))

### Sources

<a id="source-pubmed-observation-pmid-23807296-2026-01-28-8c984451104f"></a>
- **Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract. · retained source version 1:2026-01-28:current:8c984451104fec56a2c19bda1a36da424b04200d19b29b248af8a3fb12195c24** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23807296/) (`pubmed-observation-pmid-23807296-2026-01-28-8c984451104f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-23807296-thymosin-beta-4-v1 SHA-256: 0b3c172fc5bfc9516d26ac05bcf9a8626feb61c6bd2c5300deab7c8aaf1fcdeb.

---

<a id="pubmed-pmid-24704991-thymosin-beta-4-v1"></a>

## Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.

> PubMed lists PMID 24704991 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-11 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24704991-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24704991-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-24704991-thymosin-beta-4-v1
- Content SHA-256: `84e09c89b714ef63ae07ef312e4b38210b43fd6fd188dc02fc07ba9646e4ac2f`

### Claims and source pins

#### Headline

Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma. ([`pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd`](#source-pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd))

#### Summary

PubMed lists PMID 24704991 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-11 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd`](#source-pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd))

#### Paragraph 1

PubMed lists PMID 24704991 in European journal of histochemistry : EJH as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-11 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd`](#source-pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd`](#source-pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd))

### Sources

<a id="source-pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd"></a>
- **Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma. · retained source version 1:2026-01-28:current:8cb983311ebddd790dbb5ca08612e296b23c0b4985bb2ddab30d04f1aefa102f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24704991/) (`pubmed-observation-pmid-24704991-2026-01-28-8cb983311ebd`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-24704991-thymosin-beta-4-v1 SHA-256: 84e09c89b714ef63ae07ef312e4b38210b43fd6fd188dc02fc07ba9646e4ac2f.

---

<a id="pubmed-pmid-25284727-thymosin-beta-4-v1"></a>

## Extending the time window of mammalian heart regeneration by thymosin beta 4.

> PubMed lists PMID 25284727 in Journal of cellular and molecular medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25284727-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25284727-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-25284727-thymosin-beta-4-v1
- Content SHA-256: `253e9cd89f59347032087c7439234e0b53c1cd74082a59a313c6703c1a20861f`

### Claims and source pins

#### Headline

Extending the time window of mammalian heart regeneration by thymosin beta 4. ([`pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256`](#source-pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256))

#### Summary

PubMed lists PMID 25284727 in Journal of cellular and molecular medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256`](#source-pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256))

#### Paragraph 1

PubMed lists PMID 25284727 in Journal of cellular and molecular medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-10-06 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256`](#source-pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256`](#source-pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256))

### Sources

<a id="source-pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256"></a>
- **Extending the time window of mammalian heart regeneration by thymosin beta 4. · retained source version 1:2026-01-28:current:4f4947f4e2567a7c9c5bacdbc5d7eed9ecb7dc67e598e1e72521daeae5494d7f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25284727/) (`pubmed-observation-pmid-25284727-2026-01-28-4f4947f4e256`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Extending the time window of mammalian heart regeneration by thymosin beta 4." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-25284727-thymosin-beta-4-v1 SHA-256: 253e9cd89f59347032087c7439234e0b53c1cd74082a59a313c6703c1a20861f.

---

<a id="pubmed-pmid-26361868-thymosin-beta-4-v1"></a>

## Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation.

> PubMed lists PMID 26361868 in Differentiation; research in biological diversity as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-09-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26361868-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26361868-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26361868-thymosin-beta-4-v1
- Content SHA-256: `f3203fd9fa03b35e85a54f798258ca4368a838dc466329afd57360a440cf6d6e`

### Claims and source pins

#### Headline

Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation. ([`pubmed-observation-pmid-26361868-2026-01-27-faca74408544`](#source-pubmed-observation-pmid-26361868-2026-01-27-faca74408544))

#### Summary

PubMed lists PMID 26361868 in Differentiation; research in biological diversity as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-09-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26361868-2026-01-27-faca74408544`](#source-pubmed-observation-pmid-26361868-2026-01-27-faca74408544))

#### Paragraph 1

PubMed lists PMID 26361868 in Differentiation; research in biological diversity as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-09-08 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26361868-2026-01-27-faca74408544`](#source-pubmed-observation-pmid-26361868-2026-01-27-faca74408544))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26361868-2026-01-27-faca74408544`](#source-pubmed-observation-pmid-26361868-2026-01-27-faca74408544))

### Sources

<a id="source-pubmed-observation-pmid-26361868-2026-01-27-faca74408544"></a>
- **Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation. · retained source version 1:2026-01-27:current:faca744085441c4ba53d9084466423d3ab9d2c2df2ca7a115ba05763fb851bc4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26361868/) (`pubmed-observation-pmid-26361868-2026-01-27-faca74408544`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26361868-thymosin-beta-4-v1 SHA-256: f3203fd9fa03b35e85a54f798258ca4368a838dc466329afd57360a440cf6d6e.

---

<a id="pubmed-pmid-26556858-thymosin-beta-4-v1"></a>

## MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer.

> PubMed lists PMID 26556858 in Oncotarget as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-22 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26556858-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26556858-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26556858-thymosin-beta-4-v1
- Content SHA-256: `02304697ab01ae08023daab0ea9641cbdb59c24625c4b043c84a2ad015104a8a`

### Claims and source pins

#### Headline

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer. ([`pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e`](#source-pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e))

#### Summary

PubMed lists PMID 26556858 in Oncotarget as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-22 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e`](#source-pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e))

#### Paragraph 1

PubMed lists PMID 26556858 in Oncotarget as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-22 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e`](#source-pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e`](#source-pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e))

### Sources

<a id="source-pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e"></a>
- **MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer. · retained source version 1:2026-01-27:current:323ec31f383e34420c55363b3c378c3da22fed50d902e92b0985dfb534d461b5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26556858/) (`pubmed-observation-pmid-26556858-2026-01-27-323ec31f383e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26556858-thymosin-beta-4-v1 SHA-256: 02304697ab01ae08023daab0ea9641cbdb59c24625c4b043c84a2ad015104a8a.

---

<a id="pubmed-pmid-26695126-thymosin-beta-4-v1"></a>

## A thymosin beta-4 is involved in production of hemocytes and immune defense of Hong Kong oyster, Crassostrea hongkongensis.

> PubMed lists PMID 26695126 in Developmental and comparative immunology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-13 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26695126-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26695126-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26695126-thymosin-beta-4-v1
- Content SHA-256: `635f3c39b5908c1578bbd6a68a71cd5f3276e11f0df569e1018bb9cfd83541c5`

### Claims and source pins

#### Headline

A thymosin beta-4 is involved in production of hemocytes and immune defense of Hong Kong oyster, Crassostrea hongkongensis. ([`pubmed-observation-pmid-26695126-2026-01-27-85833121afa4`](#source-pubmed-observation-pmid-26695126-2026-01-27-85833121afa4))

#### Summary

PubMed lists PMID 26695126 in Developmental and comparative immunology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-13 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26695126-2026-01-27-85833121afa4`](#source-pubmed-observation-pmid-26695126-2026-01-27-85833121afa4))

#### Paragraph 1

PubMed lists PMID 26695126 in Developmental and comparative immunology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12-13 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26695126-2026-01-27-85833121afa4`](#source-pubmed-observation-pmid-26695126-2026-01-27-85833121afa4))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26695126-2026-01-27-85833121afa4`](#source-pubmed-observation-pmid-26695126-2026-01-27-85833121afa4))

### Sources

<a id="source-pubmed-observation-pmid-26695126-2026-01-27-85833121afa4"></a>
- **A thymosin beta-4 is involved in production of hemocytes and immune defense of Hong Kong oyster, Crassostrea hongkongensis. · retained source version 1:2026-01-27:current:85833121afa45556e9b3ee3b308df3c3dd8f19e9789516bf9f9fd66af7898286** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26695126/) (`pubmed-observation-pmid-26695126-2026-01-27-85833121afa4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A thymosin beta-4 is involved in production of hemocytes and immune defense of Hong Kong oyster, Crassostrea hongkongensis." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-26695126-thymosin-beta-4-v1 SHA-256: 635f3c39b5908c1578bbd6a68a71cd5f3276e11f0df569e1018bb9cfd83541c5.

---

<a id="pubmed-pmid-27130465-thymosin-beta-4-v1"></a>

## Role of thymosin beta 4 in hair growth.

> PubMed lists PMID 27130465 in Molecular genetics and genomics : MGG as Journal Article, with publication-date metadata of 2016-04-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27130465-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27130465-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-27130465-thymosin-beta-4-v1
- Content SHA-256: `7afea58d85a3301402ff42f4063eed6026eafe24e2d9e8ae835677281857c302`

### Claims and source pins

#### Headline

Role of thymosin beta 4 in hair growth. ([`pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b`](#source-pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b))

#### Summary

PubMed lists PMID 27130465 in Molecular genetics and genomics : MGG as Journal Article, with publication-date metadata of 2016-04-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b`](#source-pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b))

#### Paragraph 1

PubMed lists PMID 27130465 in Molecular genetics and genomics : MGG as Journal Article, with publication-date metadata of 2016-04-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b`](#source-pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b`](#source-pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b))

### Sources

<a id="source-pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b"></a>
- **Role of thymosin beta 4 in hair growth. · retained source version 1:2026-01-27:current:4cd8897b0c0b6c000d88e98410d2f67fb1fa10d34e30168eca66a11686683e54** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27130465/) (`pubmed-observation-pmid-27130465-2026-01-27-4cd8897b0c0b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Role of thymosin beta 4 in hair growth." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-27130465-thymosin-beta-4-v1 SHA-256: 7afea58d85a3301402ff42f4063eed6026eafe24e2d9e8ae835677281857c302.

---

<a id="pubmed-pmid-27450736-thymosin-beta-4-v1"></a>

## Cardioprotection by Thymosin Beta 4.

> PubMed lists PMID 27450736 in Vitamins and hormones as Journal Article, Review, with publication-date metadata of 2016-05-31 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27450736-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27450736-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-27450736-thymosin-beta-4-v1
- Content SHA-256: `0f449905db7f3c622339e24f6e0a1d6aba93e0098653c743fc2167ba3a92dda3`

### Claims and source pins

#### Headline

Cardioprotection by Thymosin Beta 4. ([`pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad`](#source-pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad))

#### Summary

PubMed lists PMID 27450736 in Vitamins and hormones as Journal Article, Review, with publication-date metadata of 2016-05-31 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad`](#source-pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad))

#### Paragraph 1

PubMed lists PMID 27450736 in Vitamins and hormones as Journal Article, Review, with publication-date metadata of 2016-05-31 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad`](#source-pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad`](#source-pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad))

### Sources

<a id="source-pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad"></a>
- **Cardioprotection by Thymosin Beta 4. · retained source version 1:2026-01-27:current:456c7034e7ad5db8ffec4376f681dbc87ebdf3a5abcb1b68251fa57383f86185** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27450736/) (`pubmed-observation-pmid-27450736-2026-01-27-456c7034e7ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Cardioprotection by Thymosin Beta 4." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-27450736-thymosin-beta-4-v1 SHA-256: 0f449905db7f3c622339e24f6e0a1d6aba93e0098653c743fc2167ba3a92dda3.

---

<a id="pubmed-pmid-28442910-thymosin-beta-4-v1"></a>

## Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.

> PubMed lists PMID 28442910 in International journal of nanomedicine as Journal Article, with publication-date metadata of 2017-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28442910-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28442910-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-28442910-thymosin-beta-4-v1
- Content SHA-256: `fceea1909ec2d1a51cac7438ad10271e7369ec6721256e97279bb90d969dbfb8`

### Claims and source pins

#### Headline

Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles. ([`pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590`](#source-pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590))

#### Summary

PubMed lists PMID 28442910 in International journal of nanomedicine as Journal Article, with publication-date metadata of 2017-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590`](#source-pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590))

#### Paragraph 1

PubMed lists PMID 28442910 in International journal of nanomedicine as Journal Article, with publication-date metadata of 2017-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590`](#source-pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590`](#source-pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590))

### Sources

<a id="source-pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590"></a>
- **Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles. · retained source version 1:2026-01-27:current:109a8b02e5900a4986d9a0a9bcab75a42a64c4014034314e1d3a1675214627a5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28442910/) (`pubmed-observation-pmid-28442910-2026-01-27-109a8b02e590`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-28442910-thymosin-beta-4-v1 SHA-256: fceea1909ec2d1a51cac7438ad10271e7369ec6721256e97279bb90d969dbfb8.

---

<a id="pubmed-pmid-30063853-thymosin-beta-4-v1"></a>

## Thymosin beta 4 and the eye: the journey from bench to bedside.

> PubMed lists PMID 30063853 in Expert opinion on biological therapy as Journal Article, Personal Narrative, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30063853-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30063853-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-30063853-thymosin-beta-4-v1
- Content SHA-256: `f3f3bcb5d6f9a89cfe84d5c4f2d8db907e973ba25836a8bc4b172feb88391b54`

### Claims and source pins

#### Headline

Thymosin beta 4 and the eye: the journey from bench to bedside. ([`pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442`](#source-pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442))

#### Summary

PubMed lists PMID 30063853 in Expert opinion on biological therapy as Journal Article, Personal Narrative, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442`](#source-pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442))

#### Paragraph 1

PubMed lists PMID 30063853 in Expert opinion on biological therapy as Journal Article, Personal Narrative, Review, with publication-date metadata of 2018-07 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442`](#source-pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442`](#source-pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442))

### Sources

<a id="source-pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442"></a>
- **Thymosin beta 4 and the eye: the journey from bench to bedside. · retained source version 1:2026-01-27:current:e12a4ecb644226b1e77c901a110f5414bbbaeb575419691ee5976622a868629e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30063853/) (`pubmed-observation-pmid-30063853-2026-01-27-e12a4ecb6442`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4 and the eye: the journey from bench to bedside." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-30063853-thymosin-beta-4-v1 SHA-256: f3f3bcb5d6f9a89cfe84d5c4f2d8db907e973ba25836a8bc4b172feb88391b54.

---

<a id="pubmed-pmid-30971892-thymosin-beta-4-v1"></a>

## Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance.

> PubMed lists PMID 30971892 in Frontiers in cellular neuroscience as Journal Article, with publication-date metadata of 2019-03-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30971892-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-09-30
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30971892-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-30971892-thymosin-beta-4-v1
- Content SHA-256: `e39fbb9a8feeae864fe93beab029c2b9f9c19404b2662405926a28a66f402125`

### Claims and source pins

#### Headline

Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance. ([`pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3`](#source-pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3))

#### Summary

PubMed lists PMID 30971892 in Frontiers in cellular neuroscience as Journal Article, with publication-date metadata of 2019-03-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3`](#source-pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3))

#### Paragraph 1

PubMed lists PMID 30971892 in Frontiers in cellular neuroscience as Journal Article, with publication-date metadata of 2019-03-26 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3`](#source-pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3`](#source-pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3))

### Sources

<a id="source-pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3"></a>
- **Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance. · retained source version 1:2020-09-30:current:8b53210784d33b2297d52427364cf2d4f10681de801cf9eeff36a5f9bc8a1e7e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30971892/) (`pubmed-observation-pmid-30971892-2020-09-30-8b53210784d3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin Beta 4 Is Involved in the Development of Electroacupuncture Tolerance." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-30971892-thymosin-beta-4-v1 SHA-256: e39fbb9a8feeae864fe93beab029c2b9f9c19404b2662405926a28a66f402125.

---

<a id="pubmed-pmid-31753373-thymosin-beta-4-v1"></a>

## Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application.

> PubMed lists PMID 31753373 in Materials science & engineering. C, Materials for biological applications as Journal Article, with publication-date metadata of 2019-10-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31753373-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31753373-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-31753373-thymosin-beta-4-v1
- Content SHA-256: `3eb240ecba5f8ab55f2b985ecd934feb863f2ddbd0d250bacd4da6dc94a2d69c`

### Claims and source pins

#### Headline

Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application. ([`pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3`](#source-pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3))

#### Summary

PubMed lists PMID 31753373 in Materials science & engineering. C, Materials for biological applications as Journal Article, with publication-date metadata of 2019-10-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3`](#source-pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3))

#### Paragraph 1

PubMed lists PMID 31753373 in Materials science & engineering. C, Materials for biological applications as Journal Article, with publication-date metadata of 2019-10-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3`](#source-pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3`](#source-pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3))

### Sources

<a id="source-pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3"></a>
- **Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application. · retained source version 1:2026-01-27:current:815f49f2f0c392236021ca757fb92f5022ebd808c3f1390361d443d54ecf785b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31753373/) (`pubmed-observation-pmid-31753373-2026-01-27-815f49f2f0c3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-31753373-thymosin-beta-4-v1 SHA-256: 3eb240ecba5f8ab55f2b985ecd934feb863f2ddbd0d250bacd4da6dc94a2d69c.

---

<a id="pubmed-pmid-32290541-thymosin-beta-4-v1"></a>

## Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4.

> PubMed lists PMID 32290541 in Cells as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32290541-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32290541-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-32290541-thymosin-beta-4-v1
- Content SHA-256: `d76aa8c5d3a09db02f0d6a02d18e59c5916595878fc827a8fc7caf83d5a413e4`

### Claims and source pins

#### Headline

Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4. ([`pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca`](#source-pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca))

#### Summary

PubMed lists PMID 32290541 in Cells as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca`](#source-pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca))

#### Paragraph 1

PubMed lists PMID 32290541 in Cells as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-12 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca`](#source-pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca`](#source-pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca))

### Sources

<a id="source-pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca"></a>
- **Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4. · retained source version 1:2026-01-27:current:b8205bbb22ca115529c8aee961ca3fa2be229896e32238f19480bf5c72e6cba0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32290541/) (`pubmed-observation-pmid-32290541-2026-01-27-b8205bbb22ca`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Transplantation of Endothelial Progenitor Cells in Obese Diabetic Rats Following Myocardial Infarction: Role of Thymosin Beta-4." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-32290541-thymosin-beta-4-v1 SHA-256: d76aa8c5d3a09db02f0d6a02d18e59c5916595878fc827a8fc7caf83d5a413e4.

---

<a id="pubmed-pmid-34071596-thymosin-beta-4-v1"></a>

## Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies.

> PubMed lists PMID 34071596 in Cells as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-05-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34071596-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34071596-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-34071596-thymosin-beta-4-v1
- Content SHA-256: `5cc23d15d504b3898b4faa560b3c4d431c6f120848076060285ab4361586ca28`

### Claims and source pins

#### Headline

Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. ([`pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6`](#source-pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6))

#### Summary

PubMed lists PMID 34071596 in Cells as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-05-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6`](#source-pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6))

#### Paragraph 1

PubMed lists PMID 34071596 in Cells as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-05-28 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6`](#source-pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6`](#source-pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6))

### Sources

<a id="source-pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6"></a>
- **Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. · retained source version 1:2026-01-27:current:faafc56803e6e0dafefea5b1940e2db8b1f8ca28be0b0d312b12a4434429da6c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34071596/) (`pubmed-observation-pmid-34071596-2026-01-27-faafc56803e6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-34071596-thymosin-beta-4-v1 SHA-256: 5cc23d15d504b3898b4faa560b3c4d431c6f120848076060285ab4361586ca28.

---

<a id="pubmed-pmid-35436057-thymosin-beta-4-v1"></a>

## Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients.

> PubMed lists PMID 35436057 in The Egyptian journal of immunology as Journal Article, with publication-date metadata of 2022-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35436057-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-11-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35436057-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-35436057-thymosin-beta-4-v1
- Content SHA-256: `f3c930ed03ebe20309c3f4c212be8a63b1852bbbd9cd54494f8265ab24ba11ed`

### Claims and source pins

#### Headline

Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients. ([`pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b`](#source-pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b))

#### Summary

PubMed lists PMID 35436057 in The Egyptian journal of immunology as Journal Article, with publication-date metadata of 2022-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b`](#source-pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b))

#### Paragraph 1

PubMed lists PMID 35436057 in The Egyptian journal of immunology as Journal Article, with publication-date metadata of 2022-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b`](#source-pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b`](#source-pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b))

### Sources

<a id="source-pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b"></a>
- **Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients. · retained source version 1:2026-11-09:current:8b742cc3858bdb19be82d07b027d54cd0cff388a0fa3aee7c283818ad014854f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35436057/) (`pubmed-observation-pmid-35436057-2026-11-09-8b742cc3858b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-35436057-thymosin-beta-4-v1 SHA-256: f3c930ed03ebe20309c3f4c212be8a63b1852bbbd9cd54494f8265ab24ba11ed.

---

<a id="pubmed-pmid-36445571-thymosin-beta-4-v1"></a>

## The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting.

> PubMed lists PMID 36445571 in Genes & genomics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-11-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36445571-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-30
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36445571-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-36445571-thymosin-beta-4-v1
- Content SHA-256: `4690cab9ad073c4a3f02074adbce9f67b8dd243bcc7806d6593ddc5d2f80f967`

### Claims and source pins

#### Headline

The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting. ([`pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8`](#source-pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8))

#### Summary

PubMed lists PMID 36445571 in Genes & genomics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-11-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8`](#source-pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8))

#### Paragraph 1

PubMed lists PMID 36445571 in Genes & genomics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-11-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8`](#source-pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8`](#source-pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8))

### Sources

<a id="source-pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8"></a>
- **The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting. · retained source version 1:2026-10-30:current:847fa458c6b89209fef6eeb98d4c1d1f7c8e8eb0e377c9d3fe297b1c281ef548** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36445571/) (`pubmed-observation-pmid-36445571-2026-10-30-847fa458c6b8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-36445571-thymosin-beta-4-v1 SHA-256: 4690cab9ad073c4a3f02074adbce9f67b8dd243bcc7806d6593ddc5d2f80f967.

---

<a id="pubmed-pmid-36709593-thymosin-beta-4-v1"></a>

## Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.

> PubMed lists PMID 36709593 in International immunopharmacology as Review, Journal Article, with publication-date metadata of 2023-01-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36709593-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36709593-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-36709593-thymosin-beta-4-v1
- Content SHA-256: `12eccd6d68bd191973a0ec21b4000056a1111b9d0d3a74d1136f8921cad96654`

### Claims and source pins

#### Headline

Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies. ([`pubmed-observation-pmid-36709593-2026-01-27-e9c748763366`](#source-pubmed-observation-pmid-36709593-2026-01-27-e9c748763366))

#### Summary

PubMed lists PMID 36709593 in International immunopharmacology as Review, Journal Article, with publication-date metadata of 2023-01-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36709593-2026-01-27-e9c748763366`](#source-pubmed-observation-pmid-36709593-2026-01-27-e9c748763366))

#### Paragraph 1

PubMed lists PMID 36709593 in International immunopharmacology as Review, Journal Article, with publication-date metadata of 2023-01-27 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36709593-2026-01-27-e9c748763366`](#source-pubmed-observation-pmid-36709593-2026-01-27-e9c748763366))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36709593-2026-01-27-e9c748763366`](#source-pubmed-observation-pmid-36709593-2026-01-27-e9c748763366))

### Sources

<a id="source-pubmed-observation-pmid-36709593-2026-01-27-e9c748763366"></a>
- **Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies. · retained source version 1:2026-01-27:current:e9c748763366bc2cda5f8bb666609d36b707eb42d1335ae47b6b71530a2ee6ff** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36709593/) (`pubmed-observation-pmid-36709593-2026-01-27-e9c748763366`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-36709593-thymosin-beta-4-v1 SHA-256: 12eccd6d68bd191973a0ec21b4000056a1111b9d0d3a74d1136f8921cad96654.

---

<a id="pubmed-pmid-40816274-thymosin-beta-4-v1"></a>

## Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.

> PubMed lists PMID 40816274 in Stem cell reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-14 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40816274-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40816274-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-40816274-thymosin-beta-4-v1
- Content SHA-256: `971e3f9697d444b9e4547025658a13ffff2d5409e2d5ba3f15df1ee6b4ed8fec`

### Claims and source pins

#### Headline

Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. ([`pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f`](#source-pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f))

#### Summary

PubMed lists PMID 40816274 in Stem cell reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-14 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f`](#source-pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f))

#### Paragraph 1

PubMed lists PMID 40816274 in Stem cell reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-14 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f`](#source-pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f`](#source-pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f))

### Sources

<a id="source-pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f"></a>
- **Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. · retained source version 1:2026-06-16:current:6b01089f4e9f72f5cc8aa54d6c696b9703f8c51df907ecfc3c204d8fdc0910ea** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40816274/) (`pubmed-observation-pmid-40816274-2026-06-16-6b01089f4e9f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-40816274-thymosin-beta-4-v1 SHA-256: 971e3f9697d444b9e4547025658a13ffff2d5409e2d5ba3f15df1ee6b4ed8fec.

---

<a id="pubmed-pmid-41570941-thymosin-beta-4-v1"></a>

## Thymosin beta 4: An emerging therapeutic candidate for kidney diseases.

> PubMed lists PMID 41570941 in Peptides as Journal Article, Review, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41570941-thymosin-beta-4:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-21
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41570941-thymosin-beta-4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-41570941-thymosin-beta-4-v1
- Content SHA-256: `33d5af7a6452a805f8de8ab5b4de369114c6c520777983763851095322876533`

### Claims and source pins

#### Headline

Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. ([`pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4`](#source-pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4))

#### Summary

PubMed lists PMID 41570941 in Peptides as Journal Article, Review, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4`](#source-pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4))

#### Paragraph 1

PubMed lists PMID 41570941 in Peptides as Journal Article, Review, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4`](#source-pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4`](#source-pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4))

### Sources

<a id="source-pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4"></a>
- **Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. · retained source version 1:2026-07-21:current:67da7e4d0db4df5230a6273f3b36cc9f165eb5c174a93e5383f61df57078ed4a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41570941/) (`pubmed-observation-pmid-41570941-2026-07-21-67da7e4d0db4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Thymosin beta 4: An emerging therapeutic candidate for kidney diseases." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/thymosin-beta-4.json#pubmed-pmid-41570941-thymosin-beta-4-v1 SHA-256: 33d5af7a6452a805f8de8ab5b4de369114c6c520777983763851095322876533.

